The U.S. Supreme Court ruled in an antitrust case over Chinese vitamin C exports that U.S. courts are not bound by another country's description of its own laws, but the justices only provided a few hints about how much weight to give competing evidence about what a foreign law requires, leaving trial courts to parse the deference due in future cases.
TPG reportedly wants $1.5 billion for a fund aimed at betting on technology companies putting off going public, Stryker Corp. offered to take over Boston Scientific, and the European Commision is set to approve Fortum’s bid to buy a 46.65 percent stake in Uniper
Teva Pharmaceutical and Boehringer Ingelheim on Monday announced a settlement with the last remaining party accusing them of entering into an illegal pay-for-delay agreement to keep a generic version of the stroke prevention medicine Aggrenox off the market, paving the way for the multidistrict litigation in Connecticut federal court to close out.
Qualcomm Inc. was hit Friday with a proposed shareholder class action in California federal court over Broadcom Ltd.'s thwarted $117 billion bid to take over its rival, alleging the chipmaker’s executives artificially pumped up share prices while “secretly” taking steps to kill the deal.
A D.C. federal judge came down on the side of Eagle Pharmaceuticals Inc. on Friday, ordering the U.S. Food and Drug Administration to grant orphan drug exclusivity to the company's chemotherapy drug Bendeka.
Samsung Electronics Co. Ltd. urged a California federal judge Friday to reject a request by Chinese smartphone maker Huawei to set a licensing rate for its cellular network patents in the United States, arguing that Huawei made the request too late in litigation and that it would severely hurt Samsung.
A California state appeals court on Friday affirmed a lower court’s decision to deny Uber’s bid to arbitrate claims it used fake Lyft accounts to hurt competition, finding that claims brought by a Lyft driver are unaffected by a separate agreement he signed as an Uber driver.
Engineering and mining contractor Murray & Roberts Holdings Ltd. has asked a South African competition tribunal to intervene in the shareholder vote for an alternative to Aton GmbH's $400 million takeover bid, the German investment company said Friday.
The judicial panel overseeing multiple suits accusing Merck & Co. Inc. of conspiring with generic-drug makers to delay the entry of rivals to its cholesterol drug Zetia have centralized the cases in Virginia.
The U.S. Supreme Court on Monday said it will not hear a wage suppression case brought by scouts against Major League Baseball or litigation over a contract dispute between Wrigley Field-area rooftop owners and the Chicago Cubs, deciding not to review the league's oft-criticized antitrust exemption.
Two telecom companies denied some $3.3 billion in credits for spectrum licenses reserved for small businesses have urged the Federal Communications Commission to take another look at their request, arguing their revised operating agreements create more space from DISH Network Corp.
The full Eleventh Circuit on Friday refused to revisit a recent decision rejecting class claims that Delta and AirTran Airways colluded to institute a first-checked baggage fee, allowing its original decision to stand.
Former Barclays traders and a Deutsche Bank trader fighting Euribor rigging charges “each played a significant role” in an alleged plot to manipulate interest rates, a prosecutor told a London jury on Monday as he dismissed as “absurd" the bankers’ claims they thought it was normal business practice.
The last week has seen dozens of eyewear retailers sue Visa and MasterCard, UBS look to seize property from beleaguered Indian beverage magnate Vijay Mallya and insurer HDI Global take action against Maersk. Here, Law360 looks at those and other new claims in the U.K.
An expert witness for the Federal Trade Commission in its effort to block a marine goods merger said Friday in D.C. federal court that consumer benefits touted by the companies from the proposed transaction are either unverifiable or not relevant to the deal.
The Federal Trade Commission said Friday that it has replaced its retired inspector general with a staffer from the U.S. Department of Commerce who has extensive audit experience from several governmental agencies.
Europe’s antitrust watchdog will reportedly give Comcast’s deal to buy Sky PLC its stamp of approval, Dialog Semiconductor is in negotiations with Synaptics, and Linde AG and Praxair Inc. narrowed the bidders for a trove of assets worth $4 billion.
The Federal Trade Commission has denied a request from the Louisiana Real Estate Appraisers Board to pause an administrative proceeding challenging board regulations that control appraisal fees while it appeals to the Fifth Circuit an immunity bid that the commission rejected.
The Second Circuit has rejected an antitrust suit alleging Carfax Inc.’s exclusive agreements with used car websites and car manufacturers suppressed competition for vehicle history reports, saying the used car dealer plaintiffs didn’t have enough evidence to back their claims, according to an order unsealed Friday.
European Union antitrust authorities said Friday that they’d carried out “unannounced inspections” of an undisclosed number of chemical companies suspected of antitrust violations related to the pricing of a key chemical building block used in a variety of products.
The U.K. should hand new powers to the Prudential Regulation Authority to boost the competitiveness of London’s financial and insurance firms and offset Brexit risks, a senior lawmaker has told Law360.
A D.C. federal judge has rejected the U.S. Department of Justice’s arguments that AT&T’s planned purchase of Time Warner would hurt competition and drive up consumer costs, dealing a major blow to the government’s first court challenge of a vertical merger in decades. Here, Law360 looks at how we got here, the key issues and highlights of the case.
The latest ABA annual antitrust law spring meeting ran the gamut from the government's tough new take on no-poaching pacts to hurdles innovation can cause in merger reviews— plus wide-ranging comments from the DOJ's new antitrust chief. Here's a look at Law360's coverage of three days of debates, tips and quips.
In recent weeks, regional transmission organizations have attempted to amend their Federal Energy Regulatory Commission tariffs to protect their energy and capacity markets from state subsidies for certain types of power generation. Such subsidies challenge FERC’s authority to effectively operate competitive wholesale markets, says Richard Drom of Eckert Seamans Cherin & Mellott LLC.
In presenting the core tenets of the “New Brandeis movement,” a recent article in the Journal of European Competition Law & Practice exposes a flawed understanding of the relation between anti-monopoly and American democracy, confirms concerns that this movement heralds a return to “big is bad,” and misconstrues the Chicago School’s intellectual foundations, says Joseph Coniglio of Wilson Sonsini Goodrich & Rosati PC.
It's been eight years since the U.S. Supreme Court’s ruling in Shady Grove Orthopedic Associates v. Allstate Insurance, but courts continue to wrestle with whether state statutory class action bars are enforceable in federal court, say Daniel Fong and Robert Guite of Sheppard Mullin Richter & Hampton LLP.
High prescription drug prices are increasingly a focal point in the discussion of U.S. health care spending. While there is little consensus in Congress, there has been considerable recent activity in the federal executive branch and in state legislatures, say Tom Bulleit and Rebecca Williams of Ropes & Gray LLP.
With Federal Trade Commissioner Terrell McSweeny resigning soon, acting Chairman Maureen Ohlhausen could become the sole commissioner. The FTC seems to think it can act by a 1-0 vote, but this may be unlawful and is certainly unwise, say Stephen Calkins of Wayne State University and John Villafranco of Kelley Drye & Warren LLP.
Among the proposed amendments to Rule 23 of the Federal Rules of Civil Procedure, which are scheduled to take effect Dec. 1, are specific requirements related to “front-loading.” They outline the process for seeking preliminary court approval of class action settlements and related notice plans, say Shandarese Garr and Niki Mendoza of Garden City Group LLC.
The past few years have seen a resurgence in the acquisition of physician practices, both by hospitals and by private equity firms. However, acquiring a physician group carries special challenges in view of the heavy regulation of the health care provider industry, says William Eck of Seyfarth Shaw LLP.
It is a safe bet that the U.S. Department of Justice is poised to sign on to the European agreement on Bayer’s acquisition of rival Monsanto, perhaps with a few tweaks. Even so, the Bayer-Monsanto transaction is likely to harm U.S. farmers, say Allen Grunes and Maurice Stucke, founders of The Konkurrenz Group.
How can we improve meetings in the legal industry, which tends to evolve with the speed of a tranquilized water buffalo mired in quicksand? Breaking it down to three phases can yield significant benefits, says Nicholas Cheolas of Zelle LLP.
In the final article of their series on the American Bar Association’s 66th Antitrust Law Spring Meeting, attorneys with Perkins Coie LLP offer key takeaways from some of the sessions on consumer protection.